retatrutide caneta Remedium Research Pen Guide | Use & Dose Retatrutide: UK Availability, Price, Side

The therapeutic potential and anti-inflammatory actions of semaglutide 2.4 mg once weekly in people with NASH (Fig

Ostockons-nous vos donnes et comment sont-elles protges

We help you understand what is currently available, what is still experimental, and what may be risky

Announced March 19, 2026

March 2024 : The US FDA approved a label expansion for WEGOVY based on a supplemental New Drug Application (sNDA) for the indication of reducing risks of major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal heart attack (myocardial infarction), or non-fatal stroke in adults with either overweight or obesity and established CVD

It also reduced the body weight by up to 6.5 kg from baseline